Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;9(2):340-350.
doi: 10.1002/iid3.416. Epub 2021 Mar 3.

Current research status of HLA in immune-related diseases

Affiliations
Review

Current research status of HLA in immune-related diseases

Bingnan Liu et al. Immun Inflamm Dis. 2021 Jun.

Abstract

Human leukocyte antigen (HLA), also known as human major histocompatibility complex (MHC), is encoded by the HLA gene complex, and is currently known to have the highest gene density and the most polymorphisms among human chromosomal areas. HLA is divided into class I antigens, class II antigens, and class III antigens according to distribution and function. Classical HLA class I antigens include HLA-A, HLA-B, and HLA-C; HLA class II antigens include HLA-DP, HLA-DQ, and HLA-DR; nonclassical HLA class I and II molecules include HLA-F, E, H, X, DN, DO, and DM; and others, such as complement, are class III antigens. HLA is closely related to the body's immune response, regulation, and surveillance and is of great significance in the study of autoimmune diseases, tumor immunity, organ transplantation, and reproductive immunity. HLA is an important research topic that bridges immunology and clinical diseases. With the development of research methods and technologies, there will be more discoveries and broader prospects.

Keywords: HLA; MHC; immune-related diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet. 2013;14:301‐323. - PMC - PubMed
    1. van Drongelen V, Holoshitz J. Human leukocyte antigen‐disease associations in rheumatoid arthritis. Rheum Dis Clin North Am. 2017;43(3):363‐376. - PMC - PubMed
    1. El‐Awar N, Jucaud V, Nguyen A, Epitopes HLA. The targets of monoclonal and alloantibodies defined. J Immunol Res. 2017;2017:3406230. - PMC - PubMed
    1. Busch R, Kollnberger S, Mellins ED. HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications. Nat Rev Rheumatol. 2019;15(6):364‐381. - PubMed
    1. Katagiri T, Sato‐Otsubo A, Kashiwase K, et al. Marrow donor, frequent loss of HLA alleles associated with copy number‐neutral 6pLOH in acquired aplastic anemia. Blood. 2011;118(25):6601‐6609. - PubMed

Publication types